Bellantuono Cesario, Santone Giovanni
Recenti Prog Med. 2014 Jun;105(6):254-61. doi: 10.1701/1543.16855.
Considering teratogenic risk, recent data suggest that selective serotonin reuptake inhibitors (SSRIs) can be prescribed during pregnancy, even though some SSRIs are to be considered as a second choice. In any case, antidepressive treatment during pregnancy must be carefully tailored to the pregnant woman, considering absolute risk/benefit ratio of SSRIs, but also availability of other effective treatments, as well as woman's preferences.
考虑到致畸风险，近期数据表明，尽管某些选择性5-羟色胺再摄取抑制剂（SSRI）被视为二线选择，但孕期仍可开具此类药物处方。无论如何，孕期抗抑郁治疗必须根据孕妇的具体情况谨慎调整，不仅要考虑SSRI的绝对风险/效益比，还要考虑其他有效治疗方法的可及性以及孕妇的偏好。
